<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01045954</url>
  </required_header>
  <id_info>
    <org_study_id>DCC 02-09</org_study_id>
    <nct_id>NCT01045954</nct_id>
  </id_info>
  <brief_title>A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections</brief_title>
  <official_title>A Study of the Rules for Insulin Dosing in Patients Using Multiple Daily Injections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Diabetes Care Center</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Diabetes Care Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will be conducted in subjects with Type 1 diabetes mellitus on multiple daily
      insulin injections to determine the correct insulin dosing formulas. Subjects will be
      evaluated using continuous glucose monitoring.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects with stable type 1 diabetes mellitus on multiple daily insulin injections including
      basal and bolus will be selected in order to determine the correct insulin dosing formulas.
      Subjects will be placed on continuous glucose sensor (CGMS) and an isocaloric diet. Subjects
      will have the CGMS downloaded daily and the insulin doses adjusted if necessary. Subject will
      do four SMBGs daily to calibrate CGMS and on last day a 7-point SMBG. subjects will be on
      lispro and glargine insulin. Basal insulin will be once a day.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2010</start_date>
  <completion_date type="Anticipated">October 2010</completion_date>
  <primary_completion_date type="Anticipated">August 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the mean value for the slop between the variables of total daily dose versus total basal dose.</measure>
    <time_frame>Two weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Determine the slope between the other variables: weight, total daily dose, total basal dose, insulin correction carbohydrate rate, correction factor</measure>
    <time_frame>Two weeks</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Diabetes Mellitus Type 1</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lispro Insulin and glargine insulin</intervention_name>
    <description>Continuous glucose sensor will be inserted. Subject will be on an isocaloric diet and CGM downloaded daily. Insulin basal and bolus will be adjusted based upon treatment goals until goals reached</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age: &gt;17 years

          -  Type 1 diabetes

          -  Diabetes duration &gt; 3 months

          -  On treatment with multiple daily injections either one or more basal insulin
             injections each day for 6 weeks

          -  HbA1c &lt;9.0%

          -  Stable HbA1c in the proceeding 3 months (i.e., change &lt;1%)

          -  Demonstrated adherence to visits and instructions

          -  Attend a class in meal carbohydrate content estimation or have demonstrated knowledge
             of carbohydrate counting

        Exclusion Criteria:

          -  Major stress event during or for 6 weeks before the evaluation

          -  Taking a medication that can alter insulin sensitivity

          -  Within one week of menses

          -  Unstable eating or activity pattern

          -  Pregnancy

          -  Weight gain of &gt; 1.5 kg during the preceding 3 months

          -  Serum creatinine of &gt;1.5 mg/dl

          -  Active liver disease

          -  Evidence of autonomic neuropathy, especially gastroparesis

          -  Any antidiabetic medication other than insulin

          -  Treatment with continuous subcutaneous insulin infusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Allen B. King, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Diabetes Care Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gary W Wolfe, RN</last_name>
    <phone>831-769-9355</phone>
    <email>gwolfe@diabetescarecenter.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Diabetes Care Center</name>
      <address>
        <city>Salinas</city>
        <state>California</state>
        <zip>93901</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gary S Wolfe, RN</last_name>
      <phone>831-769-9355</phone>
      <email>gwolfe@diabetescarecenter.com</email>
    </contact>
    <investigator>
      <last_name>Allen B King, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dawn Clark, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Walsh J, Roberts R. Pumping Insulin. 3rd Edition, San Diego, Torrey Pines Press. 2000</citation>
  </reference>
  <reference>
    <citation>Bode BW. Insulin Pump Therapy. In, Therapy for diabetes Mellitus and Related Disorders, fourth edition, Lebovitz H. Ed, Alexandria, VA, American Diabetes Association, 2004, p224-231</citation>
  </reference>
  <reference>
    <citation>King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: bolus dosing. J Diabetes Sci Technol. 2007 Jan;1(1):42-6.</citation>
    <PMID>19888378</PMID>
  </reference>
  <reference>
    <citation>King AB, Armstrong DU. A prospective evaluation of insulin dosing recommendations in patients with type 1 diabetes at near normal glucose control: Basal dosing. J Diabetes Sci Technol. 2007 Jan;1(1):36-41.</citation>
    <PMID>19888377</PMID>
  </reference>
  <reference>
    <citation>Davidson PC, Hebblewhite HR, Bode BW, et al. Statistically based CSII parameters correction factor, CF (1700 rule) carbohydrate-to-insulin ratio, CIR (2.8 rule) and basal-to-total ration. Diabetes Technol Ther. 2003; 3:237</citation>
  </reference>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2010</study_first_submitted>
  <study_first_submitted_qc>January 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2010</study_first_posted>
  <last_update_submitted>January 8, 2010</last_update_submitted>
  <last_update_submitted_qc>January 8, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Allen B. King, MD</name_title>
    <organization>Diabetes Care Center</organization>
  </responsible_party>
  <keyword>diabetes mellitus type 1</keyword>
  <keyword>continuous glucose monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Insulin, Globin Zinc</mesh_term>
    <mesh_term>Insulin</mesh_term>
    <mesh_term>Insulin Glargine</mesh_term>
    <mesh_term>Insulin Lispro</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>June 17, 2011</submitted>
    <returned>July 14, 2011</returned>
    <submitted>August 23, 2013</submitted>
    <returned>October 27, 2013</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

